title: Automated control of postoperative hypertension: a prospective, randomized multicenter study.
abstract: Hypertension after a cardiac operation is a frequent phenomenon. Complications resulting from this include bleeding, disruption of vascular suture lines, subendocardial ischemia, and possible cerebrovascular accidents. Treatment with sodium nitroprusside has become accepted practice to prevent these complications. To improve control of arterial blood pressure, a closed-loop system for sodium nitroprusside administration was developed. A prospective, randomized multicenter study was carried out postoperatively in 180 cardiac surgical patients to evaluate the performance of this system compared with manual control of infusion. Adherence of mean arterial blood pressure to +/- 10% of the target blood pressure occurred 85% of the time with the automatic system and 61% of the time with manual regulation (p less than 0.0001). With the automatic system, there was less hypertension (9% versus 22%; p less than 0.0001) and hypotension (6% versus 22%; p less than 0.0001). The superior control of hypertension was achieved more rapidly with less requirement for nurse regulation of infusion rate. The superior control of blood pressure resulted in less chest tube drainage in the automatic mode (720 mL versus 840 mL; p less than 0.05).
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, OH 44195-5066.
authors.forename: D M
authors.initials: DM
authors.lastname: Cosgrove
authors.forename: J H
authors.initials: JH
authors.lastname: Petre
authors.forename: J L
authors.initials: JL
authors.lastname: Waller
authors.forename: J V
authors.initials: JV
authors.lastname: Roth
authors.forename: C
authors.initials: C
authors.lastname: Shepherd
authors.forename: L H
authors.initials: LH
authors.lastname: Cohn
mesh_terms: D000368:Aged; D001794:Blood Pressure; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D005260:Female; D005292:Ferricyanides / Q000008:administration & dosage*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007260:Infusion Pumps; D008297:Male; D008838:Microcomputers; D008875:Middle Aged; D008991:Monitoring, Physiologic; D015337:Multicenter Studies as Topic; D009599:Nitroprusside / Q000008:administration & dosage*; D011446:Prospective Studies; D011897:Random Allocation
chemical_list: D005292:Ferricyanides; D009599:Nitroprusside